Disease block
C69-C72 – Bösartige Neubildungen des Auges, des Gehirns und sonstiger Teile des Zentralnervensystems
- Chapter II: Neubildungen
9Decisions
14Patient groups
Added benefit by patient group
- Considerable3
- Non-quantifiable5
- Not proven6
Diseases in this disease block
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-05-07VoranigoVorasidenibNon-quantifiable
- 2025-10-16AugtyroRepotrectinibNot proven: 2 of 2 patient groups
- 2024-11-07RetsevmoSelpercatinibNot proven
- 2024-10-17SpexotrasTrametinibConsiderable: 1 of 3 patient groupsNon-quantifiable: 2 of 3 patient groups
- 2024-10-17FinleeDabrafenibConsiderable: 1 of 3 patient groupsNon-quantifiable: 2 of 3 patient groups
- 2024-05-16KimmtrakTebentafuspConsiderable
- 2024-02-06RozlytrekEntrectinibNot proven
- 2021-02-18RozlytrekEntrectinibNot proven
- 2020-04-02VitrakviLarotrectinibNot proven
Data status: 2026-10-29